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YVONNE F. HEIJDRA, P. N. RICHARD DEKHUIjZEN, CEES L. A. van HERWAARDEN, 
and HANS Th. M. FOLGERING
Department of Pulmonary Diseases, University of Nymegen, Medical Centre Dekkerswald, Groesbeek, the Netherlands
Nocturnal desaturations during rapid eye movement (REM) sleep, caused by nonobstructive hypoven­
tilation, occur frequently in patients with chronic obstructive pulmonary disease (COPD). This is partly 
caused by decreased activity of the intercostal and accessory muscles due to a lower motor command.
The diaphragm has to compensate for the diminished activity of these muscles during REM sleep. How­
ever, in patients with COPD strength and endurance of the diaphragm may be affected by its unfavor­
able position on the length-tension curve because of hyperinflation. The aim of this study was to estab­
lish the causal relationship between respiratory muscle function and nocturnal saturation in patients 
with COPD. We hypothesized that target-flow inspiratory muscle training (TF-IMT) would improve 
nocturnal saturation. In 20 patients with stable COPD (FEVi 35.5 ± 14.1% of predicted) and a mean 
nocturnal saturation below 92% we measured maximal inspiratory pressure ( P lm a x ) ,  transdiaphrag- 
matic pressure (Pdi), maximal sustainable inspiratory pressure (SIPmax), endurance time, and noctur­
nal saturation in Weeks 0, 4, and 10. During these 10 wk 10 patients underwent TF-IMT at 60% of 
Plmax and 10 control patients received sham TF-IMT at 10% of Plmax. Plm ax, Pdi, SIPm ax, and the endur­
ance time as well as the nocturnal saturation improved significantly in the 60% training group (by 
3.0 ±1.5  kPa, 3.4 ±1 .9  kPa, 1.5 ± 1.4 kPa, 189 ± 149 s, and 1.9 ± 2.2%, respectively), whereas no 
changes occurred in the sham training group. Also, significant correlations were observed between 
the changes in Pdi, SIPm ax, and endurance time on the one hand and the change in nocturnal satura­
tion on the other. We conclude that TF-IMT improves the nocturnal saturation in patients with severe 
COPD by increasing respiratory muscle strength and endurance. Heijdra YF, Dekhuijzen PNR, van 
Herwaarden CLA, Folgering HThM. Nocturnal saturation improves by target-flow inspiratory 
muscle training in patients with COPD. am  i  r e s p ir  c r i t  c a re  m ed 1 9 9 6 , 1 5 3 :2 6 0 - 5 .
steroids (7-9). In a former study, we found a significant correla­
tion between respiratory muscle strength (maximal inspiratory 
mouth and transdiaphragm atic pressures) and nocturnal satu­
ration (10). However, it is not known if this is a causal relation­
ship. Because inspiratory muscle training can improve respira­
tory muscle strength (11-13), this may possibly lead to higher 
nocturnal saturations.
Therefore, the aim of this study was to answer the physio­
logic question o f whether there is a causal relationship between 
respiratory muscle dysfunction and nocturnal saturation. It was 
hypothesized that target-flow inspiratory muscle training (TF- 
IMT) should result in improved nocturnal saturation by increased 
respiratory muscle strength and in particular diaphragm strength, 
in patients with severe COPD.
M E T H O D S
Study Design and Training
In a single-blind intervention study the effects of TF-IMT on respira­
tory muscle performance and nocturnal saturation data were compared 
with sham TF-IMT in 20 patients with COPD, Informed consent was 
obtained from all patients. The study was approved by the Hospital Med­
ical Ethics Committee.
Inspiratory muscle training was performed at home, daily during two 
periods of 15 min using an incentive flow meter (Inspirx; Resprecare 
Medical Inc., the Hague, the Netherlands) with an added resistance in 
the mouthpiece (12). Instruction on how to use the training device was
M any patients with severe chronic obstructive pulm onary dis­
ease (COPD) have low arterial oxygen saturation during the night 
(1, 2). The most im portant reason for nocturnal desaturations 
in these patients is hypoventilation (3). The most pronounced 
falls in saturation occur during REM sleep (2), because in this 
sleep stage skeletal postural muscle tone and the activity of in­
tercostal and accessory respiratory muscles are decreased (4, 5). 
This is caused by supraspinal inhibition o f gam m a m otorneu- 
rons, and presynaptic inhibition o f afferent terminals o f  muscle 
spindles. The diaphragm escapes from reduction of activation 
during REM  sleep, because it is almost exclusively driven by a l­
pha motorneurons. It has considerably fewer muscle spindles than 
intercostal muscles and has little postural activity (6).
In  patients with COPD, however, strength and endurance of 
the diaphragm  may be affected by its unfavorable position on 
the length-tension curve because of hyperinflation and other fac­
tors such as hypoxemia, hypercapnia, and the use o f cortico-
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TABLE 1 
PATIENT CHARACTERISTICS*
TF-IMT
Variables 60% Pimax
TF-IMT
10% Pimax
Age, yr 
Pack-years 
BMI, kg/m2 
TLC, % pred 
FRC, % pred 
FEVi, % pred 
FEVi/IVC, % pred 
Kco, % pred
Pao2, kPa
P&C02, kPa
62.4 ± 8 .8
19.1 ± 7 .8  
23.7 ± 3 .3
105.0 ±  18.5
130.0 ±  22.3
38.2 ± 15.1
35.6 ± 12.5
47.6 ± 19.3 
8.6 ±1 .1  
6.1 ± 1.0
61.8 ± 7.3 
27.1 ± 1 9 .3  
23.0 ± 3.2
103.6 ±  21.7
137.7 ± 4 0 .0
32.8 ± 13.0 
32.7 ± 1 3 .0  
45.4 ± 22.1
8.7 ± 1.0
5.8 ±  0.9
Definition of abbreviations: TF-IMT = target-flow inspiratory muscle training; Pima* -  
maximal inspiratory mouth pressure; BMI = body mass index; TLC = total lung capacity; 
FRC = functional residual capacity; FEVt = forced expiratory volume in one second; 
IVC ~ inspiratory vital capacity; Kco = diffusion capacity.
* Data are expressed as means ±SD.
given by one of the investigators. The patients had to generate an in­
spiratory flow rate at which the ball in the flow meter reached the top 
o f the device (target flow). The expiration was unloaded. The adjusta­
ble leak in the flow meter was set so that the patients had to generate 
either 60% or 10% of their maximal inspiratory mouth pressure to at­
tain the target flow. Every week, a physiotherapist of our institute checked 
if the maneuvers were performed correctly. Maximal inspiratory pres­
sure ( P i max) was measured every week. If it was changed, the leak was 
adjusted according to the new P i max. The inspiratory and expiratory 
times were set at 3 s and 4 s, respectively.
Patients
Twenty patients with COPD (5 female), according to the standards of 
the American Thoracic Society (14), were selected if their mean noctur­
nal arterial oxygen saturation was lower than 92%. All patients were 
in a stable condition at the time of study as defined by a fluctuation 
in FEV, of less than 10% in the preceding 6 mo. Patients with other 
pulmonary diseases, chest wall deformations, a previous thoracotomy, 
diabetes mellitus, neuromuscular diseases, obstructive sleep apnea syn­
drome, or an overlap syndrome were excluded. None used medication 
that stimulated or depressed respiration. The patients were randomized 
to receive either TF-IMT at 60%, or sham training at 10% of their Pimax 
during 10 wk. Evaluation was performed in Weeks 0, 4, and 10. Patient 
characteristics and lung function data are summarized in Table 1. Pul­
monary medication, as shown in Table 2, was not changed during the 
study period.
Measurements
Pressure measurements (force and endurance). Maximal inspiratory and 
expiratory mouth pressures (Pimax. P E max) were measured with a device 
based on that used by Wilson and colleagues (15). A small leak (internal 
diameter 1.1 mm, length 40 mm) in the mouthpiece prevented the buc­
cal muscles from producing significant pressures and from closing the 
glottis. The pressure inside the mouthpiece was measured with a pres­
sure transducer (model DP103-32; Validyne, Northridge, CA; range ± 
40 kPa). Transdiaphragmatic pressure (Pdi) was measured with a flexi­
ble double-lumen catheter (internal diameter of each lumen 1.1 mm)
TABLE 2 
PULMONARY MEDICATION
Medication
TF-IMT
60% Pimax 
(no. patients)
TF-IMT 
10% Plmax 
(no. patients)
Inhaled beta agonists 10 10
Inhaled anticholinergics 10 6
Inhaled corticosteroids 10 10
Oral corticosteroids, 5 -1 0  mg 2 1
Oral theophyllines 8 10
introduced through the nose (16). The catheter was positioned with the 
distal opening of the gastric lumen 58 cm from the nares and the prox­
imal opening of the esophageal lumen 38 cm from the nares. The cathe­
ter was perfused with water at a constant flow rate of 99 ml/h. The pres­
sure generated by the water flow was 1.2 kPa. The proximal ends of the 
double-lumen catheter were connected to two pressure transducers. The 
zero reference point was arbitrarily set as the pressure measured at func­
tional residual capacity (F R C ) .  Pdi was calculated by subtracting esoph­
ageal pressure (Pes) from gastric pressure (Pga). Pimax. PEmax, Pes, and 
Pga were displayed on a chart recorder (BD101; Kipp & Zonen, Delft, 
the Netherlands). P d i  was measured with visual feedback on the chart 
recorder and the patients were encouraged to generate the highest deflec­
tions. LaPorta and Grassino (17) showed that in this way the highest 
Pdi values were obtained in patients with C O P D .  Pressure measurements 
were performed in sitting position, with the subjects wearing a noseclip.
Pimax (from residual volume, RV) and P E max (from TLC) were re­
peated until three reproducible measurements had been performed with 
a maximal variability of 10% (17). The highest values were used for analy­
sis. For the sake of convenience, Pimax was expressed as an absolute 
value. Predicted values for Pimax and PEmax were calculated according 
to Wilson and colleagues (15).
Respiratory muscle endurance was measured using a device similar 
to that described by Nickerson and colleagues (18). Patients inspired 
against a weighted plunger. They had to generate a certain threshold 
pressure (Pth) to lift the plunger and allow air to flow. Pth could be 
varied by adding weight to the plunger. Pth was measured inside the 
mouthpiece with a pressure transducer. There was a linear relationship 
between Pth and the weight on the plunger. The patients started with 
a load of about 10% of their Pimax and 25- or 50-g weights were added 
at 1.5-min intervals (19). They continued to breathe until they could no 
longer inspire. The total time they were able to breathe through the in­
cremental threshold device was defined as the endurance time. The pres­
sure achieved during the heaviest load tolerated for at least 45 s was 
defined as the maximal sustainable inspiratory pressure (S I P max) (19).
Nocturnal recordings. During the night oxygen saturation and heart 
rate were measured in a real-time format by a pulse oximeter (Oxyshut- 
tle; Sensor Medics, Anaheim, CA). The data were stored and digitized. 
Computerized analysis provided mean nocturnal saturation (NSao2). stan­
dard deviation, and a histogram of the distribution of % Sao2 values. 
The baseline Sao2 awake was defined as the mean saturation during the 
first 15 min of the record, when the patient was awake and lying flat
(20). Desaturation was defined as a decrease by more than 4% in oxy­
genation from the baseline saturation awake, for a period of 5 min or 
more. This definition was derived from the study of Block and colleagues
(21) who described that a desaturation was clinically noteworthy when 
a fall of 4% or more occurred and from the study of Fletcher and col­
leagues (1) who defined a nocturnal desaturation as a fall below 90% 
lasting at least 5 min.
End-tidal Pco2 ( P e t c o 2) was measured with a sampling capnograph 
(Mijnhart Capnolyser, Bilthoven, the Netherlands) by introducing a cath­
eter into the nasopharyngeal cavity through a nostril. In this way P e t c o 2 
was monitored during both mouth and nasal breathing. Because P e t c o 2 
is not representative of arterial Pco2, increases in P e t c o 2 were only used 
qualitatively as indicators of hypoventilation in combination with the 
saturation and thoracic movement signals (22),
Thoracic movements were measured \>y means ol' respiratory induc­
tive plethysmography (Vitalog, Bear Island, C A ) ,  which was used to in­
dicate if there was respiratory activity at all (23).
An electro-oculogram (EOG) was performed with surface electrodes. 
The EOG signal was used for visual scoring of wakefulness, non-REM 
and REM sleep (23). When rapid eye movements were present in combi­
nation with desaturations, it was even more likely that REM sleep was 
present (24). Oxygen saturation, heart rate, thoracic movement, electro­
oculogram and P e t c o 2 signals during the night were displayed on a six- 
channel chart recorder (BD101; Kipp & Zonen, Delft, the Netherlands). 
The next morning the nocturnal recordings were analyzed by a techni­
cian of the lung function laboratory who was unaware of the treatment 
modality. At least one episode of REM sleep should be present before 
accepting the nocturnal registration as representative. The St. Mary’s 
Hospital sleep questionnaire was used for assessing the quality of sleep 
during the preceding night (25).
Lung function and blood gas analysis. Lung function tests were per­
formed with a wet spirometer and by a closed-circuit helium-dilution
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TABLE 3
RESPIRATORY MUSCLE PERFORMANCE*
TF-IMT TF-ÎMT
60% Pimax 1 0% Pimax
Week 0 Week 10 Week 0 Week 10
Pimax/ kPa 6.2 ± 1.2 9.2 ±  2.0*5 5.6 ± 1.5 5.8 ±  1.4
% pred 81,7 ±  15.7 120.4 ± 26.8 73.0 ± 19.0 76.3 ±  18.6
Pdi, kPa 6.6 ±  1.8 10.0 ± 3.4+5 5.8 i  1.3 6.0 ±  1.6
P^max/ kPa 10.4 ± 2 .8 11.7 ± 4.0+§ 8.5 ± 2.7 7.6 ± 2 .8
% pred 90.5 ± 2 2 .0 101.5 ± 28.3 73.3 ± 22.0 64.3 ± 2 1 .2
SIPmax/ ^Pa 2.9 ± 1.7 4.4 ± 2.3*11 2.3 ± 0 .9 2.0 ±  0.8
Time, s 437 ± 2 0 9 626 ± 245*5 469 ± 2 2 3 419 ±  181
Definition of abbreviations: TF-IMT = target-flow inspiratory muscle training; Pimax =
maximal inspiratory mouth pressure; Pdi = maximal inspiratory transdiaphragmatic pres­
sure; PEmax = maximal expiratory mouth pressure; SIPm,lx = maximal sustainable inspira­
tory mouth pressure; time = endurance time.
* Data are expressed as means ± SD. 
t  p < 0.05,
i  p < 0.01 within the group.
§ p < 0.01.
II p <  0.001 between the two groups.
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Figure 1. Effects of TF-IMT on maximal inspiratory transdiaphragmatic 
pressure. Closed squares represent 60% Pimax group; open circles rep­
resent 10% Pimax group. *p < 0.05 within 60% Pimax group; ##p < 
0.01 between the two groups.
method (Pulmonet III; Sensormedics, Bilthoven, the Netherlands). Diffu­
sion capacity (Kco) was measured by the single breath-holding carbon 
monoxide method (Sensormedics 2450). Predicted spirometric values 
were taken from European Respiratory Society standards (26),
Arterial blood gas samples were taken in semirecumbent position 
at 9:00 a .m ., after the patients had been lying down for at least 15 min 
(Corning Ph 127).
Statistical Analysis
D ata are expressed as mean ± standard deviation (SD). The Wilcoxon 
signed rank test was performed to test differences within the groups af­
ter 10 wk of TF-IMT at 60% or 10% of Pimax- The Mann-Whitney U 
test was used to test the difference between the two groups after train­
ing. The Spearman correlation test was used to analyze correlations be­
tween changes in respiratory muscle performance and changes in noc­
turnal saturation. A p value <  0.05 was considered significant. For all 
analyses the SAS package (SAS Institute Inc., Cary, NC) was used.
RESULTS
Patients
Ten patients (3 female) underwent TF-IMT at 60% and 10 p a­
tients (2 female) received sham TF-IM T at 10% of their P i max. 
There were no significant differences in age, body mass index, 
lung function, and daytime arterial blood gases between the 
groups (Table 1). During the training period, daytime blood gases 
did not change in the 60% P w  group, whereas Pao2 decreased 
by 0.7 kPa in the 10% P i max group. PaCo2, FEV1( and FRC did
not change in either group. All patients finished the complete 
study period.
Effects of IMT on Maximal Respiratory Pressures and Endurance
Table 3 shows the effects of 10 wk TF-IMT on respiratory m us­
cle performance. In both groups Pdi could not be measured in 
three patients because they were not able to swallow the double­
lumen catheter. Pimax, Pdi (Figure 1), SIPmax, and the endurance 
time increased significantly in the 60% training group, while no 
change was seen in the 10% sham training group. For all para­
meters there was a significant difference between the training 
group and the control group. PEmax improved significantly in the 
60% Pimax group (1.3 ±  2.3 kPa). There was also a significant 
difference in PEmax between the two groups.
Effects of Increased Respiratory Muscle Strength and 
Endurance on Nocturnal Saturation
In the 60% Pimax group the mean subjective sleep time, assessed 
by the St. M ary’s hospital sleep questionnaire, was 4.7 ±  1.3 h
and 5.3 ± 1.5 h in Week 0 and 10, respectively. In the 10% P w  
group, the patients slept 4.8 ± 1 . 2  and 4.7 ±  1.6 h, respectively.
The effects o f  TF-IM T on nocturnal param eters are shown 
in Table 4. All desaturations were o f  the nonobstructive type and 
were caused by hypoventilation. A fter 10 wk o f  TF-IMT, N Sao2 
increased significantly by 1.9 ±  2.2% in the 60% P w  group, 
while it decreased by 0.9 ±  1.5% in the control group (p = 0.16). 
A significant difference of 2.8% developed between the two 
groups (Figure 2). A significant increase of 3.3 ± 4.8% in the 
lowest saturation was observed in the 60% Pimax group. In the 
control group no significant difference developed (p = 0.19). The 
difference in the lowest N Sao2 between the tw o groups was sig­
nificant (Figure 3). The percentage o f recording time during which 
patients were desaturated decreased by 13.2 ±  13.5% in the 60% 
Pim ax group (p <  0.05). In the 10% Pim ax group  no change oc­
curred (p = 0.68). The difference between the  groups was sig­
nificant (Figure 4). Also the percentages o f recording time dur­
ing which patients were hypoxemic (Sao2 <  90% ) (14) before and 
after TF-IMT were compared. A large improvement was observed: 
in the 60% P i max training group the percentage o f recording time 
spent at a saturation below 90% decreased from  55.5 ± 42.3% 
to 28.4 ± 35.0%, while in the sham training group the satura­
tion remained below 90% during a large part o f  the night (59.1 ± 
40.3% and 62.5 ±  37.6%, respectively) (Figure 5). In addition, 
at the start of the study seven of the 10 patients in the 60% Pimax 
training group experienced periods with a saturation below 85% 
(range 0.4 to 90% recording time, mean 18.7 ±  33.2%). The time 
spent below 85% Sao2 decreased in all these patients after TF- 
IMT, but the largest improvement was observed in the two pa­
tients with the most severe desaturations. In these patients the 
recording time spent below 85% Sao2 decreased from 90.0 to 
20.8% and from 71.2 to 3.0%, respectively.
Correlations between Respiratory Muscle Function and 
Nocturnal Saturation
Significant correlations were found between th e  change in mean 
nocturnal Sao2 and the change in Pdi (r =  0.67, p < 0.01), 
SIPmax (r = 0.54, p <  0.05), and the endurance time (0.53, p <  
0.05). The correlation coefficient between the  change in mean 
NSao2 and the change in P imax was 0.43 (p =  0.06).
DISCUSSION
The present study shows that TF-IM T at 60% o f P imax improves 
static maximal inspiratory m outh pressure, static maximal in­
spiratory transdiaphragmatic pressure, and respiratory muscle
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TABLE 4
NOCTURNAL RECORDING DATA*
TF-IMT TF-IMT
60% Pimax 10% Plma* ■
Week 0 Week 10 Week 0 Week 10
Time in bed, min 474 ±  29 466 ± 38 466 ± 33 478 ± 2 3
REM sleep, min 47 ± 1 9 466 ± 20 48 ± 19 4 7 ±  19
Non-REM sleep, min 255 ±  42 263 ± SO 242 ± 40 248 ±  47
NSao2, % 88.8 ±  3.0 90.7 ± 1 .7t§ 89.3 ± 1.9 88.4 ± 2 .7
Lowest NSao2 / % 80.3 ± 9 .6 83.6 ± 7 .8 + í 81.7 ± 4 .2 79.3 ± 6 .6
% Time des, % 18.6 ± 18.0 5 . 4 ± 5 . 4 t t 17.4 ± 2 7 .8 16.2 ± 2 3 .3
Sao2 <  90%, % time 55.5 ± 4 2 .3 28.4 ± 3 5 .0 t í 59.1 ± 40.3 62.5 ± 3 7 .6
'  n .  ' T M l  ■ I*- , r M ------ ------  ------------ i .  . .  »■■ ■■ >' ,
Definition of abbreviations: TF-IMT = target-flow inspiratory muscle training; Pimax = maximal inspiratory mouth pressure; REM = rapid 
eye movement; NSao2 “ mean nocturnal arterial oxygen saturation; % time des = percentage of recording time patients were desatu­
rated; lowest NSao2 ~ lowest nocturnal arterial oxygen saturation; Sao2 < 90%, % time = percentage of recording time patients had a 
saturation below 90%.
* Data are expressed as means ± SD,
+ p <  0,05 within the group.
*  p < 0.05.
§ p < 0.01.
endurance in patients with severe COPD. This improvement in tory pressures can be generated at RV with a gradual decrease 
respiratory muscle function  appears to  result in an increase o f  at increasing lung volumes (30). It may therefore be speculated 
the m ean and lowest nocturnal saturation, a decrease of the per- th a t expiratory muscles were also trained to some extent during 
centage o f  tim e desaturations occurred, and a reduction of tim e TF-IMT. In the present study, Pimax and Pdi were measured from 
spent below a Sao2 o f 90%, com pared with the control group 
which received sham training a t 10% Pimax. These changes sug­
gest th a t respiratory muscle function plays a  role in nocturnal 
saturation  in patients with COPD.
max ac-RV instead o f FRC, because the predicted values for Pi 
cording to Wilson and colleagues (15) were also measured at RV. 
This overestimates Pimax because of the elastic recoil pressure of
The results o f inspiratory muscle training in patients with
maxCO PD are conflicting. Some studies showed an increase in P i 
and endurance (11-13), b u t this was no t confirmed by other in­
vestigators (27-29). In these latter studies inspiratory flow, breath­
ing pattern , and  inspiratory pressure were not defined, probably 
resulting in an inadequate training stimulus (27-29). Therefore, 
in the present study the breathing pattern  (inspiration time 3 s, 
expiration tim e 4 s) as well as the target flow at a fixed inspira­
tory resistance, resulting in a fixed inspiratory pressure (60% or 
10% Pimax), were explicitly defined. As far as we know, the im ­
provement o f  Pdi by inspiratory  muscle training (Figure 1) has 
not been described before.
the lung and chest wall.
The increase in mean nocturnal Sao2 (Figure 2) could not be 
explained by an increase in daytime P ao2 or FEV,, because these 
parameters remained unchanged in the 60% training group. There­
fore, the improved nocturnal saturation may be a direct conse­
quence o f the improved respiratory muscle performance. This 
is supported by the significant correlation coefficients found be­
tween the change in respiratory muscle function and the change 
in mean nocturnal Sao2. The improvement of Pdi is then likely 
to cause a decrease in desaturation time (Figure 3) and an in­
crease in the lowest nocturnal Sao2 (Figure 4) resulting in an in­
crease o f the mean nocturnal saturation (Figure 2).
Electroencephalography was not performed in this study, so
PEmax increased significantly by 1.3 kPa in the 60% training it was not possible to obtain classical sleep staging. However,
group and a significant difference was noticed between the two 
groups. This might be explained by the fact that, before perform ­
ing an inspiratory maneuver during TF-IMT, patients were en­
couraged to expire as far as possible to make it easier to generate 
the required pressure. This was done because the highest inspira-
eye movements taken from  EOG are sufficiently characteristic 
to allow visual scoring of wakefulness, non-REM and REM  sleep 
(23). During the study, the time spent in non-REM  and REM 
sleep stages by the patients did not change.
An acclimatization night was not used because most patients
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Figure 2. Effects of TF-IMT on mean nocturnal saturation (NSao2 )- Figure 3. Effects of TF-IMT on the lowest nocturnal saturation. Closed 
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Figure 4. Effects of TF-IM T  on the percentage of recording time pa­
tients were desaturated. Closed squares represent 60% Pimax group; 
open circles represent 10% Pimax group. *p < 0.05 within 60% Pimax 
group; *p  < 0.05 between the two groups.
had undergone a nocturnal registration before and were ac­
customed to the procedure. Stradling and colleagues (2) showed 
that the mean and lowest nocturnal saturation during consecu­
tive nights were very similar in patients with COPD. Similar find­
ings were observed by G othe and colleagues (31), who studied 
the oxygen saturation and  breathing pattern during two noncon- 
secutive nights in patients with COPD. In our control group the 
m ean and lowest nocturnal Sao2 as well as the percentage of time 
patients were desaturated did not change either during the study. 
In addition, the am ount of REM sleep remained constant.
The present study was performed in a single-blind fashion, 
bu t the nocturnal recordings were analyzed by a technician of 
the lung function laboratory who was unaware of the treatment 
modality. In addition, the respiratory muscle measurements were 
perform ed without knowledge about the nocturnal saturation
data.
The course o f the present study was too short and it was not 
designed to evaluate the influence o f increased NSao2 or decreased 
desaturation time on polycythemia, cor pulmonale, cardiac ar­
rhythmias, and survival. However, in studies with a comparable 
percentage of desaturation time, adverse clinical effects were 
found. In the study o f Levi-Valensi and colleagues (32), a corre­
lation (r =  0.33) between the total duration of saturation dips 
and pulm onary hypertension in 40 patients with COPD (day­
time Pao, 8.0 to 9.3 kPa) was found. A desaturation was defined
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Figure 5. Effects of TF-IMT on the percentage of recording time the 
patient's Sao2 was lower than 90%. Each set of dots, connected by 
a line, represents one patient *p < 0.05 within 60% Pimax group; 
< 0.05 between the two groups.
as a fall o f > 4% from the baseline awake value. The mean noc­
turnal desaturation time was 56 min. These investigators also 
showed that pulmonary hypertension was only present in 6 of 
18 patients in the desaturating group. In these 18 patients the 
desaturating time was 105 min. In the 22 nondesaturating pa­
tients no pulmonary hypertension was present. These findings 
correspond with the data published by Fletcher and colleagues 
(33). These researchers found tha t the pulm onary arterial pres­
sure was significantly higher in desaturating (n = 36) than in 
nondesaturating (n = 13) patients with CO PD  and a daytime 
Pao2 > 60 mm Hg. The mean nocturnal desaturating time in the 
desaturating patients was 56 min. So, although we did not mea­
sure pulmonary arterial pressure in our patients, pulmonary 
hypertension was likely to be present in at least some of our pa­
tients, because the desaturation time in our study (88 min) is com­
parable to the desaturation time in the aforementioned studies 
in which pulmonary hypertension was found. To our knowledge, 
no placebo-controlled studies have been published on the effects 
of a decrease in desaturation time, induced by oxygen, respira­
tion stimulating medication or training, on the pulmonary ar­
tery pressure. As a consequence, the question o f whether a de­
crease in desaturation time as found in the present study to some 
extent reverses its clinical sequelae cannot be answered directly.
The data on effects o f nocturnal hypoxemia on survival are 
conflicting and difficult to compare. Connaughton and colleagues 
(20) found in 97 patients with C O PD  (FEV, 24.9 ± 9.0% of 
predicted, Pao2 55 ± 10 mm Hg) that patients who were more 
hypoxemic at night than predicted from  the regression relation­
ship during the day, had a survival similar to that o f the patients 
who were less hypoxemic than predicted. In the regression rela­
tionship, daytime Sao2 was the only predictive variable. The 
authors concluded that the severity o f  nocturnal hypoxemia did 
not influence the prognosis. However, in their study many pa­
tients were already hypoxemic during the day, so that effects of 
nocturnal hypoxemia alone on survival could not be estimated. 
In contrast, Fletcher and coworkers (34) showed in 169 patients 
with COPD (FEV! 35% of predicted, who were all normoxemic 
[daytime Pao2 >  60 mm Hg]) that desaturating patients (mean 
desaturation time [below 90% Sao2] 134 min) had a worse sur­
vival than nondesaturating patients (mean survival 2.9 ± 1.7 and 
3.7 ± 1.7 yr, respectively). Furtherm ore, 5-yr survival was also 
significantly greater in the nondesaturating group. The effects 
of oxygen on survival in the desaturating group showed a trend 
toward shorter survival in the non-oxygen-treated group. How­
ever, these investigators did not describe the am ount of oxygen 
administered nor the effects o f  oxygen on nocturnal saturation.
The increase of 1.9 ±  2.2% in the mean nocturnal saturation 
and the substantial decrease in desaturation time (13.2 ± 13.5%) 
in the 60% Pimax training group in our study might be o f clini­
cal importance, since the complications o f nocturnal hypoxemia 
as mentioned earlier were described especially in desaturating 
patients. In addition, the time spent below 90% Sao2 during the 
night was significantly reduced (Figure 5). This reduction might 
possibly reduce the risk o f developing pulm onary hypertension 
during the night.
In conclusion, this study shows that TF-IMT at 60% of Pimax
improves the nocturnal saturation in patients with COPD. This 
improvement is caused by an increased Pimax and Pdi in partic­
ular as well as an increased respiratory muscle endurance.
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